A kinetic model for the metabolic interaction of two substrates at the active site of cytochrome P450 3A4

In many cases, CYP3A4 exhibits unusual kinetic characteristics that result from the metabolism of multiple substrates that coexist at the active site. In the present study, we observed that alpha -naphthoflavone (alpha -NF) exhibited a differential effect on CYP3A4 mediated product formation as shown by an increase and decrease, respectively, of the carboxylic acid (P-2) and omega -3-hydroxylated (P-1) metabolites of losartan, while losartan was found to be an inhibitor of the formation of the 5,6-epoxide of alpha -NF. Thus, to address this problem, a kinetic model was developed on the assumption that CYP3A4 can accommodate two distinct and independent binding domains for the substrates within the active site, and the resulting velocity equations were employed to predict the kinetic parameters for all possible enzyme-substrate species. Our results indicate that the predicted values had a good fit with the experimental observations. Therefore, the kinetic constants can be used to adequately describe the nature of the metabolic interaction between the two substrate. Applications of the model provide some new insights into the mechanism of drug-drug interactions at the level of CYP3A4.